ライフサイエンスコーパス: cardiac catheterization

1 conventional cardiac angiography (hereafter, cardiac catheterization).

2 ocardiography, radionuclide scintigraphy, or cardiac catheterization).

3 aried markedly across facilities (<1->95% of cardiac catheterizations).

4 itate myocardial viability assessment during cardiac catheterization.

5 2)) without other valvular disease underwent cardiac catheterization.

6 low predicted probability of CAD undergoing cardiac catheterization.

7 med coronary artery disease (CAD) undergoing cardiac catheterization.

8 n = 587 total) from RNA samples collected at cardiac catheterization.

9 and HFpEF (n = 83), determined invasively by cardiac catheterization.

10 will not have an occluded culprit artery at cardiac catheterization.

11 coronary artery bypass surgery (CABG) after cardiac catheterization.

12 least 65 years old and undergoing diagnostic cardiac catheterization.

13 st 400 underwent coronary CT angiography and cardiac catheterization.

14 e to a programming error that did not prompt cardiac catheterization.

15 Doppler echocardiography in comparison with cardiac catheterization.

16 terization; and late VT/VF, after the end of cardiac catheterization.

17 o underwent (18)F-FDG PET/CT and concomitant cardiac catheterization.

18 low-up in 1,010 subjects undergoing elective cardiac catheterization.

19 ti-year, multicenter cohort of strokes after cardiac catheterization.

20 factor receptor-2 in 110 patients undergoing cardiac catheterization.

21 en states with and without CON regulation of cardiac catheterization.

22 nts with coronary atherosclerosis undergoing cardiac catheterization.

23 secutive aspirin-treated patients undergoing cardiac catheterization.

24 ed myocardial ischemia who were referred for cardiac catheterization.

25 ents (2,729 in a training set) who underwent cardiac catheterization.

26 sus moderate and severe CoA as determined by cardiac catheterization.

27 ent advances in non-interventional pediatric cardiac catheterization.

28 fore Fontan procedure has typically included cardiac catheterization.

29 raphy in 234 patients undergoing transradial cardiac catheterization.

30 ts who had undergone preoperative left-sided cardiac catheterization.

31 graphy) and renal angiography at the time of cardiac catheterization.

32 = 915) or (99m)Tc tetrofosmin (n = 903) and cardiac catheterization.

33 s transvalvular pressure measurements during cardiac catheterization.

34 wall might be damaged after cannulation for cardiac catheterization.

35 orted by echocardiography when compared with cardiac catheterization.

36 ease risk in a cohort of patients undergoing cardiac catheterization.

37 erse outcomes in children with PH undergoing cardiac catheterization.

38 tomy, cardiac treatments, and outcomes after cardiac catheterization.

39 of experiencing a major adverse event after cardiac catheterization.

40 n the radial artery becomes obstructed after cardiac catheterization.

41 issing data regarding race or the diagnostic cardiac catheterization.

42 uent and life-threatening complication after cardiac catheterization.

43 partly through barriers in timely access to cardiac catheterization.

44 on patient dose and operator exposure during cardiac catheterization.

45 ly reduce operator radiation exposure during cardiac catheterization.

46 atures and outcome of LFLG-AS assessed using cardiac catheterization.

47 scretion of the invasive cardiologist during cardiac catheterization.

48 in rates per 1000 CHD patients in diagnostic cardiac catheterizations (11.7 to 13.7 per 1000), struct

49 d with an increased likelihood of subsequent cardiac catheterization (22.9% vs 12.1%; adjusted odds r

50 CATHGEN biorepository of patients undergoing cardiac catheterization; 254 families (N = 827 individua

51 ss test (n=60: stress echo [62%], CMR [32%], cardiac catheterization [3%], nuclear [2%], and coronary

52 ; P < .001), and were less likely to undergo cardiac catheterization (33.8% vs 77.8%; AOR, 0.19; 95%

53 ved less aggressive interventions, including cardiac catheterization (60.7% versus 54.0%; P<0.001), p

54 cularization strategy was similar to that of cardiac catheterization; accordingly, coronary CT angiog

55 settings of coronary artery bypass grafting, cardiac catheterization, acute myocardial infarction, co

56 s in whom CABG was performed </= 1 day after cardiac catheterization (adjusted mean rates [95% CI]: 2

57 chanical circulatory support within 1 day of cardiac catheterization after adjustment for patient- an

58 er rates of equivocally and weakly indicated cardiac catheterization after admission for acute myocar

59 was to examine whether rates of appropriate cardiac catheterization after admission for acute myocar

60 Patients were more likely to undergo cardiac catheterization after computed tomography angiog

61 ed sixty-one adult Fontan patients underwent cardiac catheterization; age 26+/-3 years, men 146 (56%)

62 These progressively supplant the use of cardiac catheterization, although the value of myocardia

63 Associations between nSES and receipt of cardiac catheterization and 30-day mortality were noted

64 ,110,150 patients undergoing only diagnostic cardiac catheterization and 941,248 undergoing percutane

65 the need for new dialysis) and time between cardiac catheterization and CABG was evaluated using mul

66 ely and modestly related to the time between cardiac catheterization and CABG, with the highest incid

67 (range, 0.45-16.5 years) underwent combined cardiac catheterization and cardiovascular magnetic reso

68 phs represented 92% of examinations, whereas cardiac catheterization and computed tomography accounte

69 y of 3 key bleeding avoidance strategies for cardiac catheterization and coronary procedural (radial

70 Pressure gradients from cardiac catheterization and Doppler echocardiography wer

71 diastolic function was assessed by means of cardiac catheterization and echocardiography.

72 lusion criteria included the need for urgent cardiac catheterization and history of ACS or coronary r

73 titutions in 54 pediatric PH patients during cardiac catheterization and in 54 matched controls.

74 ediatric and Adult Congenital Treatment) for cardiac catheterization and intervention for pediatric a

75 sepsis, acute heart failure, and receipt of cardiac catheterization and mechanical ventilation accou

76 Although post-imaging use of cardiac catheterization and medical therapy increased in

77 elationships between nSES and the receipt of cardiac catheterization and mortality after acute corona

78 association between nSES and the receipt of cardiac catheterization and mortality after an acute cor

79 those tested, only 11% underwent subsequent cardiac catheterization and only 5% underwent repeat rev

80 ines for risk stratification of patients for cardiac catheterization and possible percutaneous corona

81 In this approach, diagnostic cardiac catheterization and revascularization are only u

82 Women also experienced lower use of cardiac catheterization and revascularization procedures

83 luding the use of interventional procedures (cardiac catheterization and revascularization procedures

84 al variable to study the impact of timing of cardiac catheterization and revascularization therapy on

85 The use of cardiac catheterization and revascularization was higher

86 Although overall rates of cardiac catheterization and revascularization were simil

87 n early invasive treatment strategy (routine cardiac catheterization and revascularization when appro

88 patients without obstructive CAD who undergo cardiac catheterization and to inform decision making re

89 treatment with a cholesterol-lowering agent, cardiac catheterization, and coronary artery revasculari

90 ds (IGR, cardiac magnetic resonance imaging, cardiac catheterization, and echocardiography) and index

91 performed in 54 pediatric PH patients during cardiac catheterization, and in 54 matched controls.

92 e of ablation with hemodynamic assessment by cardiac catheterization, and LA/LV structure and functio

93 gram scans, radionuclide imaging, diagnostic cardiac catheterization, and percutaneous coronary inter

94 Blood samples were collected during cardiac catheterization, and plasma levels of IL-18 and

95 We identified stress testing, cardiac catheterization, and revascularization procedure

96 /VF any time; early VT/VF, before the end of cardiac catheterization; and late VT/VF, after the end o

97 re (AOR, 0.85; 95% CI, 0.79-0.92), and prior cardiac catheterization (AOR, 0.45; 95% CI, 0.38-0.54) w

98 ation of end-diastolic pressures obtained by cardiac catheterization are necessary for the diagnosis

99 Longitudinal follow-up and confirmation by cardiac catheterization are warranted.

100 their diagnostic accuracy was compared, with cardiac catheterization as the reference standard.

101 hours) therapies and early (first 48 hours) cardiac catheterization as well as in-hospital major ble

102 21 years of age with PH undergoing 1 or more cardiac catheterization at centers participating in the

103 All patients undergoing cardiac catheterization at Duke University Medical Cente

104 e cohort, 278 symptomatic patients underwent cardiac catheterization at our institution an average of

105 Patients underwent cardiac catheterizations at 1 week and 1, 3, 6, and 10 y

106 This large cardiac catheterization-based study reports that the LFL

107 ingly adopted as the primary access site for cardiac catheterization because of patient preference, l

108 We evaluated 107 patients with cardiac catheterization before and immediately following

109 Hemodynamic data were obtained during cardiac catheterization before the hemi-Fontan procedure

110 hort of 1471 patients with CAD who underwent cardiac catheterization between 1985 and 1989 and were f

111 (19% black, 42% women) diagnosed with CAD at cardiac catheterization between 1990 and 1998 from a sin

112 ents undergoing diagnostic or interventional cardiac catheterization between January 2011 and March 2

113 936 veterans (3181 women) undergoing initial cardiac catheterization between October 1, 2007, and Sep

114 ry of cardiac disease who underwent elective cardiac catheterization between October 1, 2008, and Sep

115 h stable ischemic heart disease confirmed on cardiac catheterization between October 1, 2008, and Sep

116 ed differences in the use of CABG, PTCA, and cardiac catheterization between white versus black and H

117 Contrast media administered during cardiac catheterization can affect hemodynamic variables

118 Skills required to perform cardiac catheterization can be learned via mentored simu

119 When needed, cardiac magnetic resonance and cardiac catheterization can be obtained.

120 model for adverse outcomes after congenital cardiac catheterization can support reporting of risk-ad

121 its (380 [30.0%] vs 2581 [74.4%], P < .001), cardiac catheterization capabilities (6 [0.5%] vs 1654 [

122 ital coronary artery bypass graft surgery or cardiac catheterization capability.

123 Non-interventional pediatric cardiac catheterization continues to have an important r

124 Cardiac catheterization, coronary revascularization, acu

125 ot-for-profit plans with respect to rates of cardiac catheterization, coronary-artery bypass grafting

126 The rates of carotid endarterectomy, cardiac catheterization, coronary-artery bypass grafting

127 ed with CAD, we retrospectively analyzed the cardiac catheterization data of 97 asymptomatic type 1 a

128 ies were assessed with echocardiographic and cardiac catheterization data.

129 ging-derived CI (r=0.7; P<0.001), as well as cardiac catheterization-derived CI (r=0.6; P<0.001).

130 implications for technical considerations of cardiac catheterization, design of the catheterization l

131 incidence in those operated </= 1 day after cardiac catheterization despite their lower risk profile

132 hs to 25 years of age presenting for routine cardiac catheterization during 2015 to 2016.

133 surgery should be planned in a hospital with cardiac catheterization facilities.

134 The "routine invasive" strategy (cardiac catheterization followed by percutaneous coronar

135 seventy-four patients undergoing nonemergent cardiac catheterization followed by treatment (ie, 128 c

136 n stable patients having elective diagnostic cardiac catheterization for 1-year risks of death and MI

137 he occurrence of a major adverse event after cardiac catheterization for congenital heart disease.

138 d children undergoing a clinically indicated cardiac catheterization for evaluation of PAH and pulmon

139 (CCB) in 10 patients with BPD who underwent cardiac catheterization for evaluation of pulmonary hype

140 From 1996 to 2008, 58 patients underwent cardiac catheterization for FM, with intervention perfor

141 rospective review of all patients undergoing cardiac catheterization for FM.

142 high-dose clopidogrel in patients undergoing cardiac catheterization for planned percutaneous coronar

143 f applicability, and safety, it is replacing cardiac catheterization for the assessment of AS in many

144 raphy) study, 371 patients underwent CTA and cardiac catheterization for the detection of obstructive

145 Patients underwent biventricular EMB, cardiac catheterization (for exclusion of coronary arter

146 The timing of cardiac catheterization, for whom catheterization is ind

147 ted probability of obstructive CAD underwent cardiac catheterization; for example, only 19.3% (95% CI

148 without known disease who underwent elective cardiac catheterization had obstructive coronary artery

149 The field of cardiac catheterization has evolved, performing more int

150 ors to improve skills relevant to performing cardiac catheterization has not been evaluated.

151 sensitization procedure was performed before cardiac catheterization in all patients, except for thos

152 d [Pyr(1)]apelin-13 were assessed by MRI and cardiac catheterization in anesthetized rats.

153 more recent advances in echocardiography and cardiac catheterization in assessment of aortic stenosis

154 The risk of cardiac catheterization in children and young adults wit

155 dren) vs low-dose UFH (50 U/kg bolus) during cardiac catheterization in children.

156 (95% CI, 18.7%-19.9%) of patients undergoing cardiac catheterization in New York had a greater than 5

157 th stable coronary artery disease undergoing cardiac catheterization in New York State between 2003 a

158 ovincial registry of all patients undergoing cardiac catheterization in Ontario, to evaluate patients

159 currence of VT/VF before or after the end of cardiac catheterization in patients presenting for prima

160 The role of cardiac catheterization in pediatric cardiology has chan

161 ions and to increase the diagnostic yield of cardiac catheterization in routine clinical practice.

162 t to fulfill its promise to replace invasive cardiac catheterization in selected patient populations.

163 We identified adult patients who underwent cardiac catheterization including coronary angiography b

164 a group more deserving of early referral to cardiac catheterization is a question warranting further

165 ested that the time to cardiac surgery after cardiac catheterization is inversely related to postoper

166 dization for adverse events after congenital cardiac catheterization is needed to equitably compare p

167 Cardiac catheterization is performed in moderate- and hi

168 Cardiac catheterization is routinely used as a diagnosti

169 Cardiac catheterization is the standard of care procedur

170 with TOF/PA, routine preoperative diagnostic cardiac catheterization is usually performed to determin

171 Procedures in the cardiac catheterization lab are more complex, take longe

172 As the cardiac catheterization lab continues to evolve, the dem

173 The cardiac catheterization lab has concerns for both patien

174 The role of the anesthesiologist in the cardiac catheterization lab must be defined in this chan

175 iologist is becoming an integral part of the cardiac catheterization lab team, and an important eleme

176 mal complications in the evolving modern day cardiac catheterization lab.

177 sessment, Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program.

178 fluoroscopic exposure rates in contemporary cardiac catheterization laboratories (CCL).

179 collects data from approximately 85% of the cardiac catheterization laboratories in the United State

180 states that had weak or no regulation of new cardiac catheterization laboratories, and in wealthier a

181 nd quality improvement activity performed in cardiac catheterization laboratories, but best practices

182 greement exists about whether hospitals with cardiac catheterization laboratories, but without onsite

183 acking (CART) program representing all 76 VA cardiac catheterization laboratories, we evaluated all p

184 ST-segment elevation myocardial infarction, cardiac catheterization laboratory (CCL) activation by e

185 ith a novel protocol of early transport to a cardiac catheterization laboratory (CCL) for extracorpor

186 Rapid activation of a cardiac catheterization laboratory (CCL) has reduced doo

187 ing nurses from intensive care units for the cardiac catheterization laboratory (lower by 0.44 percen

188 above the median OxPL/apoB presented to the cardiac catheterization laboratory a mean of 3.9 years e

189 The frequency of false-positive cardiac catheterization laboratory activation for suspec

190 d leads to increased rates of false-positive cardiac catheterization laboratory activation, unnecessa

191 d/or ventricular fibrillation (VT/VF) in the cardiac catheterization laboratory among patients underg

192 hin Cardiac ARIA 1A locations (hospital with cardiac catheterization laboratory and all aftercare wit

193 cific ischemia will be the gatekeeper to the cardiac catheterization laboratory and will transform th

194 assessment of coronary artery disease in the cardiac catheterization laboratory are reviewed.

195 ble method predicts periprocedural MI in the cardiac catheterization laboratory before it occurs.

196 A cardiac catheterization laboratory database used by 19 h

197 Particular adaptations to the cardiac catheterization laboratory environment are requi

198 s and outcomes in patients presenting to the cardiac catheterization laboratory for myocardial infarc

199 allowing for patient triage directly to the cardiac catheterization laboratory from the field.

200 approval process for developing an HOR in a cardiac catheterization laboratory in a VA designated fo

201 ergency department physician to activate the cardiac catheterization laboratory is a key strategy to

202 The incidence of CIHB in the pediatric cardiac catheterization laboratory is low at 2.2%.

203 hibitors for selective administration in the cardiac catheterization laboratory only to patients unde

204 All procedures were performed within a cardiac catheterization laboratory or hybrid operating r

205 0 minutes, and scene departure to patient on cardiac catheterization laboratory table </=30 minutes.

206 th a time from scene departure to arrival on cardiac catheterization laboratory table of </=30 minute

207 atching, the median time from arrival in the cardiac catheterization laboratory to first balloon was

208 t a similar approach could be applied in the cardiac catheterization laboratory to protect reperfused

209 atients received anesthesia in the pediatric cardiac catheterization laboratory, and 51 were deeply s

210 ar function are not readily available in the cardiac catheterization laboratory.

211 e reasons as to why we still need BMS in our cardiac catheterization laboratory.

212 routinely performed post-operatively in the cardiac catheterization laboratory.

213 or introducing a second anticoagulant in the cardiac catheterization laboratory.

214 nd 1:118 in participants ascertained via the cardiac catheterization laboratory.

215 nd management of CI-AKI as it applies to the cardiac catheterization laboratory.

216 ation of patients prior to activation of the cardiac catheterization laboratory.

217 ients analyzed, 8037 (44.8%) underwent early cardiac catheterization less than 48 hours following pre

218 Radiation exposure during cardiac catheterization, limited image planes, and poor

219 Echocardiogram, cardiac catheterization, magnetic resonance imaging, nuc

220 MR is complementary and the role of invasive cardiac catheterization may be diminishing.

221 Cardiac catheterization (n=122, 36%) demonstrated a mean

222 In subjects undergoing cardiac catheterization (n=2597), we identified cases wi

223 studied echocardiographically (n=23) and by cardiac catheterization (n=5) after primary repair (n=4)

224 The primary outcome was cardiac catheterization not leading to revascularization

225 METHODS AND Acute infarction was induced by cardiac catheterization of domestic swine.

226 tion or anesthesia for radiological imaging, cardiac catheterization, office-based surgery, and pedia

227 re referred because of equivocal findings at cardiac catheterization or echocardiography; in one, the

228 ion imaging to determine subsequent rates of cardiac catheterization or noninvasive imaging.

229 York and the comparison states in the use of cardiac catheterization or PTCA after the CABG report ca

230 eath, nonfatal myocardial infarction, repeat cardiac catheterization, or repeat CABG, there was a tre

231 ysis remains unestablished in the setting of cardiac catheterization, owing to unique concerns regard

232 invasive reference central BP waveforms from cardiac catheterization patients.

233 clinical ELISAs using 72 plasma samples from cardiac catheterization patients.

234 tion (primary outcome), invasive management (cardiac catheterization, PCI, or CABG), revascularizatio

235 York State (New York) perform twice as many cardiac catheterizations per capita as those in Ontario

236 Reduced rates of cardiac catheterization, percutaneous coronary intervent

237 myocardial infarction (MI), unstable angina, cardiac catheterization, percutaneous transluminal coron

238 Post baseline cardiac catheterization performance assessment, 27 cardi

239 Cardiac catheterization performance was reassessed 1 wee

240 We reviewed 210 700 cardiac catheterizations performed over a 35-year period

241 st incorporating only variables known before cardiac catheterization (pre-PCI model), and the second

242 Of 457 170 cardiac catheterization procedures among 336 853 patient

243 Ischemic strokes after cardiac catheterization procedures, although uncommon, l

244 patients scheduled for electrophysiology and cardiac catheterization procedures.

245 This study examined short-term cardiac catheterization rates and medication changes aft

246 Cardiac catheterization rates varied substantially acros

247 Guidelines for triaging patients for cardiac catheterization recommend a risk assessment and

248 Patients were drawn from the cardiac catheterization registry of the Intermountain He

249 Blacks were also less likely to receive cardiac catheterization, revascularization procedures, o

250 left-side irradiated patients also underwent cardiac catheterization revealing 12 of 13 with coronary

251 1 (access to principal referral center with cardiac catheterization service </=1 hour) to 8 (no ambu

252 Cardiac catheterization, standard lung function testing

253 Analysis of serial cardiac catheterization studies showed that RV and LV fi

254 tudies in animals and in patients undergoing cardiac catheterization suggest that cocaine constricts

255 Forty consecutive patients underwent cardiac catheterization, TEE, and MR.

256 Secondary end points included invasive cardiac catheterization that did not show obstructive CA

257 nts (mean 86 years, 46% female) referred for cardiac catheterization to evaluate AS also underwent tr

258 The Radiation Reduction During Cardiac Catheterization Using Real-Time Monitoring study

259 angina and coronary artery disease underwent cardiac catheterization via radial access and performed

260 During cardiac catheterization via radial access, they performe

261 down is not routinely required for pediatric cardiac catheterization via the carotid artery.

262 diac magnetic resonance imaging was 1.82, by cardiac catheterization was 1.65, and by echo was 1.7 L.

263 iovascular risk factors, the main reason for cardiac catheterization was an acute coronary syndrome (

264 n-based cohort of stable patients undergoing cardiac catheterization was assembled from April 1, 2006

265 Cardiac catheterization was common (71% and 51%), but pe

266 tive of a major adverse event or death after cardiac catheterization was derived in 70% of the cohort

267 were contacted to determine if postoperative cardiac catheterization was performed and examination of

268 Prestage II cardiac catheterization was performed at a mean age of 1

269 The benefits also persisted when cardiac catheterization was performed in control patient

270 A single cardiac catheterization was performed on each patient wi

271 ays, crude mortality for patients undergoing cardiac catheterization was slightly higher in New York

272 ac function assessed by echocardiography and cardiac catheterization was unaffected.

273 Cardiac catheterization was used as the standard of refe

274 Consecutive cases of ischemic stroke after cardiac catheterization were abstracted retrospectively

275 Patients undergoing cardiac catheterization were enrolled and categorized ac

276 total of 66 cases of ischemic strokes after cardiac catheterization were identified over 3 to 4 year

277 onsecutive patients within IMPACT undergoing cardiac catheterization were identified.

278 New York State, patients undergoing elective cardiac catheterization were significantly more likely t

279 age 58 +/- 8 years) referred for diagnostic cardiac catheterization were studied.

280 Echocardiography and cardiac catheterization were used in mice to assess the

281 A total of 19,608 cardiac catheterizations were performed between January

282 t ventricular EF (echocardiography) and then cardiac catheterization, where left ventricular pressure

283 or coronary artery bypass surgery undergoing cardiac catheterization who had at least 1 SVG graft.

284 ACS patients undergoing cardiac catheterization with >or=1 nonobstructive native

285 o intracoronary adenosine in patients during cardiac catheterization with angiographically normal ant

286 ectively), both immediately before and after cardiac catheterization with coil and particle embolizat

287 tients with LGSAS and preserved EF underwent cardiac catheterization with comparison of hemodynamic m

288 thoracic echocardiography within 48 hours of cardiac catheterization with direct measurement of LAP.

289 Among patients undergoing cardiac catheterization with planned percutaneous corona

290 trial, subjects with HFpEF (n=26) underwent cardiac catheterization with simultaneous expired gas an

291 jects with HFpEF (N = 28) underwent invasive cardiac catheterization with simultaneous expired gas an

292 Animals underwent cardiac catheterization with VIR implantation via a tran

293 A subset underwent cardiac catheterizations with liver biopsy.

294 had CCTA and 32 (16%) who had MPI underwent cardiac catheterization within 1 year.

295 ection fraction of >or=45% underwent MPI and cardiac catheterization within 15 d.

296 e logistic regression to compare the odds of cardiac catheterization within 2 and 30 days of admissio

297 Tl/stress (99m)Tc dual-isotope gated MPS and cardiac catheterization within 3 mo.

298 associated with a 6% lower odds of receiving cardiac catheterization within 30 days (P=0.01) and a 14

299 e first 24 h and were less likely to undergo cardiac catheterization within 48 h.

300 ses additional serious risks associated with cardiac catheterization, yielding a non-radiogenic risk